Amag Pharmaceuticals Business Finance Contracts & Agreements
71 Contracts & Agreements
- Credit Agreements (1 contract)
- Exchange Agreements (11)
- Indenture Agreements (6)
- Note Agreements (2)
- Purchase Agreements (3)
- Registration Rights Agreements (1)
- Share Agreements (1)
- Shareholders Agreements (2)
- Stock Agreements (36)
- Underwriting Agreements (6)
- Warrant Agreements (2)
- Supplemental Indenture, dated as of November 16, 2020, among AMAG Pharmaceuticals, Inc., Covis Finco S. r.l. and Wilmington Trust, National Association (Filed With SEC on November 17, 2020)
- Supplemental Indenture, dated as of November 16, 2020, between AMAG Pharmaceuticals, Inc. and Wilmington Trust, National Association (Filed With SEC on November 17, 2020)
- Supplemental Indenture, dated as of November 16, 2020, among AMAG Pharmaceuticals, Inc., Covis Finco S. r.l. and Wilmington Trust, National Association (Filed With SEC on November 17, 2020)
- Supplemental Indenture, dated as of November 16, 2020, between AMAG Pharmaceuticals, Inc. and Wilmington Trust, National Association (Filed With SEC on November 17, 2020)
- Asset Purchase Agreement, dated May 21, 2020, by and between AMAG Pharmaceuticals, Inc. and Millicent Pharma Limited (Filed With SEC on May 22, 2020)
- Form of Restricted Stock Unit Agreement - Non-Plan Inducement Grant (Filed With SEC on May 11, 2020)
- Form of Non-Qualified Stock Option Agreement - Non-Plan Inducement Grant (Filed With SEC on May 11, 2020)
- Contract Manufacturing Agreement, dated September 1, 2018, by and between AMAG Pharmaceuticals, Inc. and Fresenius Kabi Austria GmbH (Certain confidential information contained in... (Filed With SEC on March 1, 2019)
- Contract Manufacturing Agreement, dated September 1, 2018, by and between AMAG Pharmaceuticals, Inc. and Fresenius Kabi Austria GmbH (Certain confidential information contained in... (Filed With SEC on November 2, 2018)
- Commercial Supply Agreement, dated June 4, 2018, by and between AMAG Pharmaceuticals, Inc. and SAFC, Inc. (Certain confidential information contained in this exhibit was omitted... (Filed With SEC on August 3, 2018)
- Distribution and Supply Agreement, dated December 20, 2017, by and between AMAG Pharmaceuticals, Inc. and Prasco, LLC (Certain confidential information contained in this exhibit... (Filed With SEC on August 3, 2018)
- Form of Restricted Stock Unit Agreement - Non-Plan Inducement Grant (Filed With SEC on August 3, 2018)
- Stock Purchase Agreement, dated June 14, 2018, by and among AMAG Pharmaceuticals, Inc., CBR Acquisition Holdings Corp. and GI Chill Acquisition LLC (Filed With SEC on June 15, 2018)
- Manufacturing Agreement, dated March 20, 2018, by and between AMAG Pharmaceuticals, Inc. and Antares Pharma, Inc. (Certain confidential information contained in this exhibit was... (Filed With SEC on May 4, 2018)
- First Amendment to Development and License Agreement, dated March 20, 2018, by and between AMAG Pharma USA, Inc. (f/k/a Lumara Health, Inc.), AMAG Pharmaceuticals, Inc. and... (Filed With SEC on May 4, 2018)
- Form of Restricted Stock Unit Agreement - Non-Plan Inducement Grant (Filed With SEC on March 1, 2018)
- Form of Non-Qualified Stock Option Agreement - Non-Plan Inducement Grant (Filed With SEC on March 1, 2018)
- AMAG PHARMACEUTICALS, INC. AND WILMINGTON TRUST, NATIONAL ASSOCIATION, as Trustee FIRST SUPPLEMENTAL INDENTURE Dated as of May 10, 2017 to Indenture Dated as of May 10, 2017 3.25%... (Filed With SEC on May 15, 2017)
- AMAG PHARMACEUTICALS, INC. Issuer AND WILMINGTON TRUST, NATIONAL ASSOCIATION Trustee INDENTURE Dated as of May 10, 2017 (Filed With SEC on May 15, 2017)
- AMAG PHARMACEUTICALS, INC. 3.25% Convertible Senior Notes due 2022 Underwriting Agreement (Filed With SEC on May 8, 2017)
- AMAG PHARMACEUTICALS, INC. and AMERICAN STOCK TRANSFER & TRUST COMPANY, LLC as Rights Agent RIGHTS AGREEMENT Dated as of April 7, 2017 RIGHTS AGREEMENT (Filed With SEC on April 10, 2017)
- [***] INDICATES MATERIAL THAT HAS BEEN OMITTED AND FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED. ALL SUCH OMITTED MATERIAL HAS BEEN FILED WITH THE SECURITIES AND EXCHANGE... (Filed With SEC on April 5, 2017)
- [***] INDICATES MATERIAL THAT HAS BEEN OMITTED AND FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED. ALL SUCH OMITTED MATERIAL HAS BEEN FILED WITH THE SECURITIES AND EXCHANGE... (Filed With SEC on April 5, 2017)
- AMAG PHARMACEUTICALS, INC. RESTRICTED STOCK UNIT AWARD AGREEMENT FOR NON-EMPLOYEE DIRECTORS (Filed With SEC on August 9, 2016)
- AMAG PHARMACEUTICALS, INC. RESTRICTED STOCK UNIT AWARD AGREEMENT NON-PLAN INDUCEMENT GRANT (Filed With SEC on February 24, 2016)
- AMAG PHARMACEUTICALS, INC. RESTRICTED STOCK UNIT AWARD AGREEMENT FOR NON-EMPLOYEE DIRECTORS (Filed With SEC on February 24, 2016)
- AMAG PHARMACEUTICALS, INC. RESTRICTED STOCK UNIT AWARD AGREEMENT FOR COMPANY EMPLOYEES (Filed With SEC on February 24, 2016)
- 3,150,000 Shares AMAG Pharmaceuticals, Inc. UNDERWRITING AGREEMENT (Filed With SEC on July 31, 2015)
- STOCK PURCHASE AGREEMENT by and among CBR HOLDCO, LLC, CBR ACQUISITION HOLDINGS CORP. and AMAG PHARMACEUTICALS, INC. June 29, 2015 (Filed With SEC on June 29, 2015)
- Lunar Representative, LLC c/o Shareholder Representative Services LLC 1614 15thStreet, Suite 200 Denver, CO 80202 (Filed With SEC on May 6, 2015)
- FIRST AMENDMENT TO CREDIT AGREEMENT (Filed With SEC on May 6, 2015)
- Lunar Representative, LLC c/o Shareholder Representative Services LLC 1614 15thStreet, Suite 200 Denver, CO 80202 (Filed With SEC on May 6, 2015)
- AMAG PHARMACEUTICALS, INC. 3,977,272 Shares of Common Stock Underwriting Agreement (Filed With SEC on February 26, 2015)
- [***] INDICATES MATERIAL THAT HAS BEEN OMITTED AND FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED. ALL SUCH OMITTED MATERIAL HAS BEEN FILED WITH THE SECURITIES AND EXCHANGE... (Filed With SEC on February 18, 2015)
- [***] INDICATES MATERIAL THAT HAS BEEN OMITTED AND FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED. ALL SUCH OMITTED MATERIAL HAS BEEN FILED WITH THE SECURITIES AND EXCHANGE... (Filed With SEC on February 18, 2015)
- [***] INDICATES MATERIAL THAT HAS BEEN OMITTED AND FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED. ALL SUCH OMITTED MATERIAL HAS BEEN FILED WITH THE SECURITIES AND EXCHANGE... (Filed With SEC on February 18, 2015)
- Trade Date: February 11, 2014 Effective Date: The third Exchange Business Day immediately prior to the Premium Payment Date Warrants: Equity call warrants, each giving the holder... (Filed With SEC on February 14, 2014)
- AMAG PHARMACEUTICALS, INC. AND WILMINGTON TRUST, NATIONAL ASSOCIATION, as Trustee FIRST SUPPLEMENTAL INDENTURE Dated as of February 14, 2014 to Indenture for Senior Debt... (Filed With SEC on February 14, 2014)
- AMAG PHARMACEUTICALS, INC. Issuer AND WILMINGTON TRUST, NATIONAL ASSOCIATION, Trustee INDENTURE Dated as of February 14, 2014 Senior Debt Securities (Filed With SEC on February 14, 2014)
- AMAG PHARMACEUTICALS, INC. 2.50% Convertible Senior Notes due 2019 Underwriting Agreement (Filed With SEC on February 14, 2014)
